Reliable ray tracing for calculating IOL power

Article

Ray tracing with patient-customized eye models is effective in calculating IOL power, claims a recent case series study.

Using ray tracing with patient-customized eye models is an effective procedure in calculating IOL power, claims a case series study in the Journal of Cataract and Refractive Surgery.

Dr Carmen Canovas et al., Hospital Universitario Virgen de la Arrixaca, Murcia, Spain, calculated optimum IOL power using ray tracing with a patient-customized eye model in those requiring cataract surgery. There were 18 non-LASIK patients and 10 LASIK patients included in the study. The results for IOL power predictions were compared with the optimum postoperative IOL power.

The standard approach to IOL calculation and the ray-tracing technique gave similar mean absolute residual error and variance in non-LASIK patients. In all LASIK patients the ray-tracing procedure was the most accurate.

Differences between the prediction of IOL power with corneal aberrations and without was linked to the amount of corneal spherical aberration. In some cases this resulted in a difference of up to 3.00 D in IOL power.

Ray tracing using patient-customized eye models was found to be a strongly successful tool for IOL power calculation. But corneal aberrations must be incorporated in post-LASIK eyes due to increased corneal spherical aberration.

The full abstract can be found in the Journal of Cataract and Refractive Surgery, click here

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.